Seeing Is Believing
CASI is currently covered by 3 analysts with an average price target of $14.5. This is a potential upside of $12.16 (519.66%) from yesterday's end of day stock price of $2.34.
CASI Pharmaceuticals's activity chart (see below) currently has 3 price targets and 10 ratings on display. The stock rating distribution of CASI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 95.25 days.
Highest price target for CASI is $12, Lowest price target is $12, average price target is $14.5.
Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 15-Nov-2023. First documented stock forecast 24-Mar-2020.
Currently out of the existing stock ratings of CASI, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
12
$8.89 (285.85%)
10
5 months 3 days ago
0/3 (0%)
$7.65 (175.86%)
Buy
4
1 years 5 months 2 days ago
1/2 (50%)
$0.72 (21.95%)
73
Buy
12
$8.89 (285.85%)
1 years 8 months 3 days ago
1/2 (50%)
$7.98 (198.51%)
308
Buy
50
1 years 10 months 23 days ago
0/1 (0%)
$32.3 (182.49%)
What is CASI (CASI Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CASI (CASI Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CASI (CASI Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CASI (CASI Pharmaceuticals)?
Which analyst is the currently most bullish on CASI (CASI Pharmaceuticals)?
Which analyst is the currently most reserved on CASI (CASI Pharmaceuticals)?